These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 10846465
1. [Undifferentiated blastic cell crisis of chronic myelogenous leukemia with myeloblastic tumor in the skin]. Kawakami K, Kiyosaki M, Amaya H, Nakamaki T, Hino K, Tomoyasu S. Rinsho Ketsueki; 2000 Apr; 41(4):334-40. PubMed ID: 10846465 [Abstract] [Full Text] [Related]
2. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement]. Fujiwara H, Takahashi N, Tada J, Higuchi T, Harada H, Mori H, Niikura H, Omine M, Fujita K. Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272 [Abstract] [Full Text] [Related]
3. [Extramedullary blast crisis of mixed precursor T lymphoblastic and myeloblastic features in a patient with chronic myelogenous leukemia successfully treated with low-dose oral etoposide]. Konaka Y, Namiuchi S. Rinsho Ketsueki; 1993 Dec; 34(12):1556-61. PubMed ID: 8295329 [Abstract] [Full Text] [Related]
4. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia. Akashi K, Mizuno S, Harada M, Kimura N, Kinjyo M, Shibuya T, Shimoda K, Takeshita M, Okamura S, Matsumoto I. Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698 [Abstract] [Full Text] [Related]
11. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone]. Kuyama J, Take H. Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171 [Abstract] [Full Text] [Related]
12. [Triploid clone observed at blastic crisis in chronic myelogenous leukemia with complex Ph1 translocation (9; 22; 12)]. Ito K, Murakami S, Oku N, Takeda N, Shimazaki C, Nakanishi S, Nishio A, Haruyama H, Nakagawa M, Fujita N. Rinsho Ketsueki; 1989 Apr; 30(4):558-62. PubMed ID: 2769978 [Abstract] [Full Text] [Related]
13. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor. Murase T, Suzuki R, Tashiro K, Morishima Y, Nakamura S. Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456 [Abstract] [Full Text] [Related]
14. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis. Derderian PM, Kantarjian HM, Talpaz M, O'Brien S, Cork A, Estey E, Pierce S, Keating M. Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302 [Abstract] [Full Text] [Related]
15. [Blast crisis of chronic myelogenous leukemia with blasts expressing both immature B lymphocyte- and myelomonocyte-associated antigens and differentiating into basophils in vitro]. Utsunomiya Y, Iwamasa K, Yasukawa M, Tamai T, Shiosaka T, Bando S. Rinsho Ketsueki; 1990 Jul; 31(7):1017-21. PubMed ID: 2214182 [Abstract] [Full Text] [Related]